Purple Biotech Ltd (PPBT)
NASDAQ: PPBT · Real-Time Price · USD
0.7753
-0.6447 (-45.40%)
Sep 4, 2025, 11:32 AM - Market open
Purple Biotech Market Cap
Purple Biotech has a market cap or net worth of $4.15 million as of September 4, 2025. Its market cap has decreased by -65.95% in one year.
Market Cap
4.15M
Enterprise Value
-1.64M
1-Year Change
-65.95%
Ranking
Category
Stock Price
$0.78
Market Cap Chart
Since July 14, 2013, Purple Biotech's market cap has decreased from $4.97M to $4.15M, a decrease of -16.48%. That is a compound annual growth rate of -1.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2025 | 4.15M | -62.52% |
| Dec 31, 2024 | 11.07M | -48.88% |
| Dec 31, 2023 | 21.67M | -19.15% |
| Dec 29, 2022 | 26.80M | -60.87% |
| Dec 30, 2021 | 68.47M | 2.08% |
| Dec 31, 2020 | 67.08M | 364.70% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 662.38B |
| Johnson & Johnson | 428.68B |
| AbbVie | 374.26B |
| UnitedHealth Group | 278.84B |
| AstraZeneca | 254.65B |
| Novo Nordisk | 253.55B |
| Novartis AG | 248.54B |
| Abbott Laboratories | 230.05B |